Literature DB >> 10768870

What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis.

M Takata1, N Yamanaka, T Tanaka, J Yamanaka, S Maeda, E Okamoto, H Yasojima, K Uematsu, H Watanabe, Y Uragari.   

Abstract

BACKGROUND: Although there have been extensive studies to determine risk factors affecting survival after resection for hepatocellular carcinoma (HCC), we still do not know which patients can survive disease free after curative resection. This study was undertaken to determine independent risk factors affecting the length of disease-free survival.
METHODS: 171 patients, who survived disease free more than 1 year after curative resection, were divided into four groups according to the disease-free period: Group I (n = 96) for the patients with intrahepatic recurrence between 1 and 3 postoperative years, Group II(n = 27) for those between 3 and 5 years, Group III (n = 40) for those between 5 and 10 years and Group IV (n = 8) for those without recurrence within 10 years. The 37 variables (host factors, tumor factors, non-tumor liver factors, surgical factors) were compared among the four groups. Activity of hepatitis and hepatic fibrosis was scored by the Histological Activity Index (HAI). In a multivariate study, possible prognostic variables with a statistical difference in the disease-free survival rate among each category were preliminarily selected from the 37 variables and the independent variables were finally selected using a proportional hazard analysis.
RESULTS: The patients' age, indocyanine green retention rate, microscopic tumor capsular invasion and portal invasion, cell differentiation, extent of hepatectomy, aggressiveness of chronic hepatitis and inflammatory activity assessed by HAI score were significantly different among the four groups. In the multivariate analysis, the following variables were selected as the independent determinants favorable for achieving a longer disease-free period: younger age, lower indocyanine green retention rate, solitary HCC with expansive growth, no microscopic portal invasion and lower activity of co-existing hepatitis.
CONCLUSIONS: The importance of inflammatory activity in addition to aging, hepatic reserve and tumor characteristics was confirmed as a risk factor for recurrence by multivariate analysis. To achieve better disease-free survival, not only early detection but also suppression of co-existing hepatitis is necessary.

Entities:  

Mesh:

Year:  2000        PMID: 10768870     DOI: 10.1093/jjco/hyd016

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  13 in total

1.  Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

Authors:  Kenji Oyama; Keita Kanki; Hiroki Shimizu; Yohei Kono; Junya Azumi; Kan Toriguchi; Etsuro Hatano; Goshi Shiota
Journal:  Gastrointest Tumors       Date:  2016-08-03

2.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 3.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Total vascular exclusion technique for resection of hepatocellular carcinoma.

Authors:  Zhen-Yu Yin; Xiao-Ming Wang; Ren-Xiang Yu; Bai-Meng Zhang; Ke-Ke Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer.

Authors:  Xue-Ping Zhou; Zhi-Wei Quan; Wen-Ming Cong; Ning Yang; Hai-Bin Zhang; Shu-Hui Zhang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

6.  Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo.

Authors:  Lan Wang; Jueheng Wu; Jie Yuan; Xun Zhu; Hongmei Wu; Mengfeng Li
Journal:  Front Med       Date:  2016-01-20       Impact factor: 4.592

7.  Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis.

Authors:  Toshia Ochiai; Teruhisa Sonoyama; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chohei Sakakura; Yuji Ueda; Eigo Otsuji; Hirosumi Itoi; Akeo Hagiwara; Hisakazu Yamagishi
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-10       Impact factor: 4.553

8.  Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.

Authors:  Atsushi Nanashima; Kenji Tanaka; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Megumi Yoshinaga; Terumitsu Sawai; Tohru Nakagoe; Hiroyoshi Ayabe
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

9.  Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Kenichi Matsuo; Kazuhisa Takeda; Yasuhiko Nagano; Shinji Togo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

10.  ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma.

Authors:  Ryouichi Tsunedomi; Norio Iizuka; Kiyoshi Yoshimura; Michihisa Iida; Masahito Tsutsui; Noriaki Hashimoto; Shinsuke Kanekiyo; Kazuhiko Sakamoto; Takao Tamesa; Masaaki Oka
Journal:  Int J Oncol       Date:  2013-03-08       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.